Clinical Trial Update: The Possible Effects of Roflumilast on Obesity Related Disorders [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating roflumilast for obesity-related disorders including obesity and prediabetes has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Prediabetes

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: Tanta University | Conditions: Obesity, PreDiabetes | Phase 3 | Status: COMPLETED